Regulations

L’Oréal Issues Recall of Effaclar Duo

Lab testing found high levels of benzene in acne treatments.

In response to lab testing, L’Oreal has issued a voluntary recall of its Effaclar Duo in the U.S. According to the recall, independent U.S. lab Valisure found high levels of benzene in acne treatments containing benzoyl peroxide (BPO) made by several companies. A larger list was revealed on the FDA website, as seen here. The recall noted that benzene is a known carcinogen that can form at high levels in products containing BPO, a common ingredient for killing acne-causing bacteria. The...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters